We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

MorphoSys to Receive Milestone Payment for Guselkumab Program

News   Apr 14, 2015

 
MorphoSys to Receive Milestone Payment for Guselkumab Program
 
 
Advertisement
 

RELATED ARTICLES

Like a Stamped Passport, SARS-Cov-2 Mutations Tell a Tale of Its Transmission in the US

News

The coronavirus, responsible for the COVID-19 pandemic, has one official name—SARS-CoV-2. But according to virologists, mutations lead to hundreds of genetically-distinct versions of the virus. Scientists at Children’s Hospital Los Angeles have used these viral signatures to reveal transmission patterns, which show the effectiveness of early safety measure policies.

READ MORE

Ancient DNA Elements Can Activate a Powerful Immune Response to Cancer Cells

News

Ancient embedded elements in our DNA from generations past can activate a powerful immune response to kill cancer cells like an infection.

READ MORE

FDA Approves Remdesivir for COVID-19

News

The US Food and Drug Administration has approved the antiviral drug Veklury (remdesivir) for use in adult and pediatric patients (≥ 12 years of age and weighing at least 40 kg) for the treatment of COVID-19 requiring hospitalization.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE